BREAST CANCER RECURRENT

Clinical trials for BREAST CANCER RECURRENT explained in plain language.

Never miss a new study

Get alerted when new BREAST CANCER RECURRENT trials appear

Sign up with your email to follow new studies for BREAST CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

Hope for breast cancer patients: new drug combo may delay recurrence

Disease control Ongoing

This phase 3 trial tests whether adding the drug palbociclib to standard hormone therapy can help prevent breast cancer from coming back in people with a specific type of breast cancer (HR+/HER2-). About 405 participants who had surgery for a local or regional recurrence will rec…

Matched conditions: BREAST CANCER RECURRENT

Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC

BREAST CANCER RECURRENT

Get alerted when new BREAST CANCER RECURRENT trials appear

Hope for breast cancer patients: new drug combo may delay recurrence